Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Mining and evaluation of security alert signals of neuroprotective agents based on the Jinan adverse event reporting system database: a retrospective study.

PMID: 40837401 · 2025

JournalFrontiers in pharmacology
Year2025
PMID40837401

Abstract

Pharmacologic agents with proposed neuroprotective properties are increasingly investigated; however, limited regulation and heterogeneous evidence raise concerns about their safety profiles. To establish a foundation for its safe clinical use, the data mining technology was used to investigate the safety warning signals of neuroprotective agent post-market approval. The Jinan adverse event (AE) reporting system database was searched for AEs related to neuroprotective agents from January 2000 to

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.